Latest Alimta Stories
INDIANAPOLIS, May 15, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the English High Court has determined that the vitamin dosage regimen patents for Alimta(®)
Japanese research suggests a biomarker called osteopontin could help some mesothelioma patients avoid the trial-and-error approach to treatment. Raleigh, NC
INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S.
Japanese researchers say the drug Alimta (pemetrexed) in combination with cisplatin should remain the top first-line treatment for malignant pleural mesothelioma. Raleigh,
- The act of sweetening by admixture of some saccharine substance.